Back
Amplify Natural Resources DivETF Vs. Aligos Therapeutics Industry Stock Comparison
Sell
31
NDIV
Amplify Natural Resources DivETF
Last Price:
28.75
Seasonality Move:
-0.88%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Sell
31
Amplify Natural Resources DivETF (NDIV)
is a Sell
Is Amplify Natural Resources DivETF a Buy, Sell or Hold?
- The current Amplify Natural Resources DivETF [NDIV] share price is $28.54. The Score for NDIV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NDIV Stock Price Chart
What is Amplify Natural Resources DivETF's stock price today?
-
The Amplify Natural Resources DivETF share price today is $28.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NDIV is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NDIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 40.85 | Sell |
Chaikin Money Flow: | -437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.68 - 29.56) | Sell |
Bollinger Bands (100): | (28.25 - 29.29) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.32 | Buy |
Relative Strength Index (14 RSI): | 81.62 | Buy |
Chaikin Money Flow: | 315379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 26.46) | Buy |
Bollinger Bands (100): | (7.85 - 19.03) | Buy |
NDIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.14 | Sell |
20-day SMA: | 29.21 | Sell |
50-day SMA: | 28.95 | Sell |
200-day SMA: | 28.81 | Sell |
8-day EMA: | 29 | Sell |
20-day EMA: | 29.09 | Sell |
50-day EMA: | 28.96 | Sell |
200-day EMA: | 28.53 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 22.81 | Buy |
50-day SMA: | 14.24 | Buy |
200-day SMA: | 15.81 | Buy |
8-day EMA: | 27.13 | Buy |
20-day EMA: | 22.88 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 15.94 | Buy |
Amplify Natural Resources DivETF Earnings Growth & NDIV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Amplify Natural Resources DivETF Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |